Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
About
This Notice of Funding Opportunity (NOFO) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and sustainable dissemination of the technologies to the wider biomedical research community. A BTOD Center should be at the leading edge of its field with respect to both technology optimization and engagement with relevant research communities. BTOD projects must address biomedical research areas within the NIGMS mission. Potential applicants are strongly encouraged to consult with NIGMS staff about adherence of their proposed research strategy to the Institute's goals and mission and its responsiveness to this NOFO.
The Biomedical Technology Optimization and Dissemination Center (BTOD) grant, supported by the National Institute of General Medical Sciences (NIGMS), is designed for research institutions and organizations advancing cutting-edge biomedical technologies. This funding opportunity supports late-stage technology optimization and the sustainable dissemination of innovative technologies to the broader biomedical research community. BTOD Centers must demonstrate leadership in both technology development and active engagement with relevant research communities within the NIGMS mission areas. Researchers and institutions with mature biomedical technologies seeking to scale impact, improve accessibility, and expand adoption across the research landscape should consider applying. This grant is ideal for organizations positioned at the forefront of their field, ready to transition technologies from development into widespread use. The program emphasizes sustainability and community-driven dissemination strategies. Applicants are encouraged to consult with NIGMS staff prior to submission to ensure their proposed research aligns with institute goals. This is a competitive opportunity for those demonstrating both technological excellence and commitment to broader scientific impact.
Funding Facts
● Applications openDeadline
January 29, 2029
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by funding cycle
Deadline
2029-01-29
Grant Type
federal
Application Cycle
Annual - Next deadline January 29, 2029
Best For
Research institutions and organizations with mature biomedical technologies ready for optimization and broad dissemination within the NIGMS mission
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Frequently Asked Questions
Who is eligible for Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)?
U.S. domestic organizations are eligible to apply. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible. However, foreign components as defined in the NIH Grants Policy Statement are allowed within eligible U.S. organizations. For complete eligibility requirements, refer to Section III of the official Notice of Funding Opportunity (NOFO) on the NIGMS website.
How much funding does Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) provide?
Funding amounts vary by funding cycle. Consult the official NIGMS BTOD NOFO and contact NIGMS program staff for current funding levels and budgetary details specific to the application cycle you are considering.
How do I apply for Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)?
Applications are submitted through the NIH grants application system. Before submitting, applicants are strongly encouraged to consult with NIGMS staff to ensure their proposed research strategy aligns with institute goals and the NOFO requirements. Visit the official NIGMS website and the NIH grants portal for detailed application instructions, submission deadlines, and required documentation. The next deadline is January 29, 2029.
What can Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) funding be used for?
Funding supports late-stage technology optimization and sustainable dissemination of biomedical technologies to the research community. Projects must align with the NIGMS mission and cannot include clinical trials. Funds may support technology refinement, validation, community engagement, dissemination infrastructure, and activities that advance adoption of technologies across the biomedical research landscape.
Last updated: July 5, 2026